147 related articles for article (PubMed ID: 6154784)
1. Immune complexes in multiple sclerosis: relation to clinical pattern.
Patzold U; Haller P; Baruth B; Liman W; Deicher H
J Neurol; 1980; 222(4):249-60. PubMed ID: 6154784
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in patients with multiple sclerosis. A longitudinal study of serum and CSF by C1q and platelet binding tests.
Arnadottir T; Kekomäki R; Lund GA; Reunanen M; Salmi AA
J Neurol Sci; 1982 Sep; 55(3):273-83. PubMed ID: 6982312
[TBL] [Abstract][Full Text] [Related]
3. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis. Characterization and correlation with the clinical course.
Procaccia S; Lanzanova D; Caputo D; Ferrante P; Papini E; Gasparini A; Colucci A; Bianchi M; Villa P; Blasio R
Acta Neurol Scand; 1988 May; 77(5):373-81. PubMed ID: 3046225
[TBL] [Abstract][Full Text] [Related]
5. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
Cojocaru M; Serbănescu A; Cojocaru IM
Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in multiple sclerosis. Relation to clinical and biological parameters.
Davous P; Jacque CM; Grangeot-Keros L; Marteau R; Baumann N
Biomedicine; 1978 May; 29(3):103-6. PubMed ID: 687746
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases.
Salmi A; Ziola B; Reunanen M; Julkunen I; Wager O
Acta Neurol Scand; 1982 Jul; 66(1):1-15. PubMed ID: 7113673
[TBL] [Abstract][Full Text] [Related]
8. Soluble immune complexes in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
Glikmann G; Svehag SE; Hansen E; Hansen O; Husby S; Nielsen H; Farrell C
Acta Neurol Scand; 1980 Jun; 61(6):333-43. PubMed ID: 6998248
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis. Cerebrospinal fluid immune complexes that bind C1q.
Rudick RA; Bidlack JM; Knutson DW
Arch Neurol; 1985 Sep; 42(9):856-8. PubMed ID: 3875333
[TBL] [Abstract][Full Text] [Related]
10. Characterization of immune complexes in multiple sclerosis by an antigen-specific immune complex radioimmunoassay.
Lund GA; Arnadottir T; Hukkanen V; Reunanen M; Salmi A
J Neuroimmunol; 1983 Jun; 4(3):253-64. PubMed ID: 6853697
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes and complement in the course of multiple sclerosis.
Jans H; Heltberg A; Raun NE
Acta Neurol Scand; 1982 Oct; 66(4):488-96. PubMed ID: 6216715
[TBL] [Abstract][Full Text] [Related]
13. [Detection of circulating immune complexes by three techniques using polyethylene glycol (author's transl)].
Digeon M; Bach JF
Nouv Presse Med; 1977 Dec; 6(43):4031-7. PubMed ID: 600749
[TBL] [Abstract][Full Text] [Related]
14. The covalent interaction of C3 with IgG immune complexes.
Vivanco F; Muñoz E; Vidarte L; Pastor C
Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.
Stanilova SA; Slavov ES
J Immunol Methods; 2001 Jul; 253(1-2):13-21. PubMed ID: 11384665
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
Santoro F; Bout D; Camus D; Capron A
Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
[No Abstract] [Full Text] [Related]
17. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid immune complexes in multiple sclerosis.
Deicher H; Meyer zu Schwabedissen H; Baruth B; Patzold U; Haller P
Experientia; 1979 Sep; 35(9):1249-50. PubMed ID: 488296
[TBL] [Abstract][Full Text] [Related]
19. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)].
Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J
Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016
[TBL] [Abstract][Full Text] [Related]
20. Control of immune complexes by the classical pathway.
Whaley K; Ahmed AE
Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
